Abstract
Steroid receptor coactivator-1 (SRC-1) has a crucial role in many different biological effects mediated by nuclear receptors. However, in spite of its ubiquitous expression, there are no data regarding its possible involvement in nuclear receptor transcriptional activity at the level of the peripheral nervous system. We investigated whether this coactivator might have a role in the control of glycoprotein Po gene expression. This myelin protein is a specific product of Schwann cells, with a fundamental role in the maintenance and functionality of peripheral myelin. Po is known to be stimulated by progesterone and by its 5α-reduced metabolite, dihydroprogesterone (DHP), through the corresponding steroid receptor. To determine whether the effect exerted by DHP on Po mRNA levels could be affected by and therefore associated with altered levels of SRC-1, a mouse Schwann cell line was stably transfected to over- or underexpress this coactivator. We found that SRC-1 overexpressing cells are more responsive to Po mRNA induction by DHP, whereas the effect of the steroid is completely lost in SRC-1-deficient cells. Interestingly, SRC-1 levels are also positively correlated with Po gene expression independently of DHP exposure. Finally, DHP treatment increases not only Po but also SRC-1 mRNA levels. Altogether, these data indicate for the first time that in rat Schwann cells, SRC-1 plays a role in the regulation of one of the most typical proteins of peripheral myelin.
Similar content being viewed by others
References
Aranda A. and Pascual A. (2001) Nuclear hormone receptors and gene expression. Transcriptional termination factor for RNA polymerase 2 in yeast. Mol. Cell 7, 1003–1014.
Azcoitia I., Leonelli E., Magnaghi V., Veiga S., Garcia-Segura L. M., and Melcangi R. C. (2003) Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol. Aging 24, 853–860.
Baron-Van Evercooren A., Duhamel-Clerin E., Boutry J. M., Hauw J. J., and Gumpel M. (1993) Pathways of migration of transplanted Schwann cells in the demyelinated mouse spinal cord. J. Neurosci. Res. 35, 428–438.
Bocquel M. T., Kumar V., Stricker C., Chambon P., and Gronemeyer H. (1989) The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. Nucleic Acids Res. 17, 2581–2595.
Bousios S., Karandrea D., Kittas C., and Kitraki E. (2001) Effects of gender and stress on the regulation of steroid receptor coactivator-1 expression in the rat brain and pituitary. J. Steroid Biochem. Mol. Biol. 78, 401–407.
Boutry J. M., Hauw J. J., Gansmuller A., Di-Bert N., Pouchelet M., and Baron-Van Evercooren A. (1992) Establishment and characterization of a mouse Schwann cell line which produces myelin in vivo. J. Neurosci. Res. 32, 15–26.
Chan J. R., Phillips L. J. II, and Glaser M. (1998) Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc. Natl. Acad. Sci. USA 95, 10459–10464.
Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal. Biochem. 162, 156–159.
Desarnaud F., Bidichandani S., Patel P. I., Baulieu E. E., and Schumacher M. (2000) Glucocorticosteroids stimulate the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. Brain Res. 865, 12–16.
Desarnaud F., Do Thi A. N., Brown A. M., Lemke G., Suter U., Baulieu E. E., and Schumacher M. (1998) Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J. Neurochem. 71, 1765–1768.
Detrait E., Laduron S., Meremans V., Baron-Van Evercooren A., van den Bosch de Aguilar P., and Knoops B. (1999) Expression of integrins by murine MSC80 Schwann cell line: relationship to cell adhesion and migration. Neurosci. Lett. 267, 49–52.
Eichberg J. (2002) Myelin P0: new knowledge and new roles. Neurochem. Res. 27, 1331–1340.
Feltri M. L., Scherer S. S., Wrabetz L., Kamholz J., and Shy M. E. (1992) Mitogen-expanded Schwann cells retain the capacity to myelinate regenerating axons after transplantation into rat sciatic nerve. Proc. Natl. Acad. Sci. U. S. A. 80, 8827–8831.
Garbay B., Heape A. M., Sargueil F., and Cassagne C. (2000) Myelin synthesis in the peripheral nervous system. Prog. Neurobiol. 61, 267–304.
Glass C. K. and Rosenfeld M. G. (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14, 121–141.
Guennoun R., Benmessahel Y., Delespierre B., Gouezou M., Rajkowski K. M., Baulieu E. E., and Schumacher M. (2001) Progesterone stimulates Krox-20 gene expression in Schwann cells. Mol. Brain Res. 90, 75–82.
Jenster G., Spencer T. E., Burcin M. M., Tsai S. Y., Tsai M. J., and O’Malley B. W. (1997) Steroid receptor induction of gene transcription: a two-step model. Proc. Natl. Acad. Sci. USA 94, 7879–7884.
Jung-Testas I., Do Thi A., Koenig H., Desarnaud F., Shazand K., Shumacher M., and Baulieu E. E. (1999) Progesterone as a neurosteroid: synthesis and actions in rat glial cells. J. Steroid Biochem. Mol. Biol. 69, 97–107.
Jung-Testas I., Shumacher M., Robel P., and Baulieu E. E. (1996) Demonstration of progesterone receptors in rat Schwann cells. J. Steroid Biochem. Mol. Biol. 58, 77–82.
Kamiya Y., Zhang X. Y., Ying H., Kato Y., Willingham M. C., Xu J., et al. (2003) Modulation by steroid receptor coactivator-1 of target-tissues responsiveness in resistance to thyroid hormone. Endocrinology 144, 4144–4153.
Kurihara I., Shibata H., Toshihiko S., Ando T., Kobayashi S., Matsuhiko M., et al. (2002) Expression and regulation of nuclear receptor coactivators in glucocorticoid action. Mol. Cell. Endocrinol. 189, 181–189.
Lemke G. and Axel R. (1985) Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 40, 501–508.
Leo C. and Chen J. D. (2000) The SRC family of nuclear receptor coactivators. Gene 245, 1–11.
Magnaghi V., Cavarretta I., Galbiati M., Martini L., and Melcangi R. C. (2001) Neuroactive steroids and peripheral myelin proteins. Brain Res. Rev. 37, 360–371.
Magnaghi V., Cavarretta I., Zucchi I., Susani L., Rupprecht R., Hermann B., et al. (1999) Po gene expression is modulated by androgens in the sciatic nerve of adult males rats. Mol. Brain Res. 70, 36–44.
Magnaghi V., Riva M. A., Cavarretta I., Martini L., and Melcangi R. C. (2000) Corticosteroids regulate the gene expression of FGF-1 and FGF-2 in cultured rat astrocytes. J. Mol. Neurosci. 15, 11–18.
Matsumoto A. (2002) Age-related changes in nuclear receptor coactivator immunoreactivity in motoneurons of the spinal nucleus of the bulbocavernosus of male rats. Brain Res. 943, 202–205.
McKenna N. J., Lanz R. B., and O’Malley B. W. (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20, 321–344.
Meijer O. C., Steenbergen P. J., and De Kloet E. R. (2000) Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary. Endocrinology 141, 2192–2199.
Melcangi R. C., Ballabio M., Cavarretta I., Gonzalez L. C., Leonelli E., Veiga S., et al. (2003) Effects of neuroactive steroids on myelin of peripheral nervous system. J. Steroid Biochem. Mol. Biol. 85, 323–327.
Melcangi R. C., Magnaghi V., Cavarretta I., Martini L., and Piva F. (1998) Age-induced decrease of glycoprotein Po and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives. Neuroscience 85, 569–578.
Melcangi R. C., Magnaghi V., Cavarretta I., Zucchi I., Bovolin P., D’urso D., and Martini L. (1999) Progesterone derivatives are able to influence peripheral myelin protein 22 and Po gene expression: possible mechanism of action. J. Neurosci Res. 56, 349–357.
Melcangi R. C., Magnaghi V., Galbiati M., Ghelarducci M., Sebastiani L., and Martini L. (2000) The action of steroid hormones on peripheral myelin proteins: a possible new tool for the rebuilding of myelin? J. Neurocytol. 23, 327–339.
Melcangi R. C., Magnaghi V., Galbiati M., and Martini L. (2001) Formation and effects of neuroactive steroids in the central and peripheral nervous system. Int. Rev. Neurobiol. 46, 145–176.
Misiti S., Schomburg L., Yen P., and Chin W. (1998) Expression and hormonal regulation of coactivator and core-pressor genes. Endocrinology 139, 2493–2500.
Nicholson S. M., Gomes D., Baron-Van Evercooren A., and Bruzzone R. (1999) Induction of myelin gene expression in murine Schwann cells in primary culture and in a Schwann cell line. Ann. N. Y. Acad. Sci. 883, 513–517.
Nishihara E., Yoshida-Komiya H., Chan C., Liao L., Davis R., O’Malley B., and Xu J. (2003) SRC-1 null mice exhibit moderate motor dysfunction and delayed development of cerebellar Purkinje cells. J. Neurosci. 23, 213–222.
Onate S. A., Tsai S. Y., Tsai M.-J. and O’Malley B. W. (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354–1357.
Onate S. A., Boonyaratanakornkit V., Spencer T. E., Tsai S. Y., Tsai M.-J., Edwards D. P., and O’Malley B. W. (1998) The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptor. J. Biol. Chem. 20, 12101–12108.
Robert F., Guennoun R., Desarnaud F., Do-Thi A., Benmessahel Y., Baulieu E. E., and Schumacher M. (2001) Synthesis of progesterone in Schwann cells: regulation by sensory neurons. Eur. J. Neurosci. 13, 916–924
Schumacher M., Guennoun R., Mercier G., Desarnaud F., Lacor P., Benavides J., et al. (2001) Progesterone synthesis and myelin formation in peripheral nerves. Brain Res. Rev. 37, 343–359.
Shiozawa T., Shih H. C., Miyamoto T., Feng Y. Z., Uchikawa J., Itoh K., and Konishi I. (2003) Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium. J. Clin. Endocrinol. Metab. 88, 871–878.
Spencer T. E., Jenster G., Burcin M. M., Allis C. D., Zhou J., Mizzen C. A., et al. (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389, 194–198.
Suter U. and Scherer S. (2003) Disease mechanisms in inherited neuropathies. Nat. Rev. Neurosci. 4, 714–726.
Takeuchi Y., Murata Y., Sadow P., Hayashi Y., Seo H., Xu J., et al. (2002) Steroid receptor coactivator-1 causes variable alterations in the modulation of t(3)-regulated transcription of genes in vivo. Endocrinology 143, 1346–1352.
Tetel M., Giangrande P., Leonhardt S., McDonnel D., and Edwards D. (1999) Hormone-dependent interaction betwenn the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Mol. Endocrinol. 13, 910–924.
Warner L. E., Garcia C. A., and Lupski J. R. (1999) Hereditary peripheral neuropathies: clinical forms, genetics, and molecular mechanisms. Annu. Rev. Med. 50, 263–275.
Weiss R. E., Xu J., Ning G., Pohlenz J., O’Malley B. W., and Refetoff S. (1999) Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. Endocrinology 18, 1900–1904.
Wieser F., Schneeberger C., Hudelist G., Singer C., Kurz C., Nagele F., et al. (2002) Endometrial nuclear receptor co-factors SRC-1 and N-CoR are increased in human endometrium during mesturation. Mol. Hum. Reprod. 8, 644–650.
Wrabetz L., Feltri M. L., Quattrini A., Imperiale D., Previtali S., D’Antonio M., et al. (2000) P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J. Cell Biol. 148, 1021–1034.
Xu J., Qui Y., DeMayo F. J., Tsai M., and O’Malley B. W. (1998) Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279, 1922–1925.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cavarretta, I.T.R., Martini, L., Motta, M. et al. SRC-1 is involved in the control of the gene expression of myelin protein po. J Mol Neurosci 24, 217–226 (2004). https://doi.org/10.1385/JMN:24:2:217
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:24:2:217